Wana Brands Expands Product Lines to Maryland


Ryan Allway

January 29th, 2020

News


Wana Brands, the country’s leading producer of infused cannabis products, has partnered with Curio Wellness to bring America’s top selling cannabis infused medicinal products to patients throughout Maryland.

Since 2010, Wana Brands has expanded from Colorado into six additional states, with Maryland being seventh. Wana became the No. 1 cannabis infused product in the United States, with more dollars sold than any other brand, by leading the industry in quality, innovation, and most notably, building strategic relationships with award-winning, respected cannabis brands throughout the country.

“Curio Wellness is the leading cannabis company in Maryland, and we were extremely impressed by the professionalism and the quality of the facility and the team. They are proven operators who really know how to execute,” said Nancy Whiteman, CEO, Wana Brands.

As a vertically integrated company, Curio’s manufacturing processes and institutional knowledge of the Maryland market – from seed to store – are unmatched. Wana’s diverse line of products will be held to the same cultivation and processing standards that both companies take pride in.

“We are excited to partner with Wana Brands to expand our medicinal product line for all Maryland patients. At Curio, we are committed to offering only the highest quality, most effective products all consumers can rely on. Partnering with Wana not only complements that commitment, but also who we are as a company.” said Michael Bronfein, CEO, Curio Wellness.

Like Wana, Curio is a science-driven producer, offering award-winning medicinal cannabis products throughout Maryland. Today, Curio products are available in most Maryland dispensaries, including in their own flagship store and wellness center in Timonium, outside Baltimore.

“The flagship store serves as a tremendous resource for the company’s research and development efforts,” Bronfein said. “What our team of experienced executives and renowned researchers and physicians learn first-hand helps define our product portfolio and best serve our retail partners and patients.”

Curio Wellness plans to begin production in the second quarter, bringing Wana products to market in Maryland in Summer 2020.

Wana Brands: Enhance Your Life.

Included in the 2019 Inc. 5000 list at #1536 and boasting a three-year growth rate of 269%, Wana Brands is the No. 1 infused brand in the United States, with more dollars sold than any other brand, according to BDS Analytics 2018 Brand Share Report. Wana leads the industry in quality, consistency and potency, providing a range of different options that enable customers to create the specific cannabis experience they want. Wana products offer diverse product forms including infused products, vapes and extended release capsules, four different CBD/THC ratios as well as a variety of different dosages, onset times and duration of effects. The portfolio is designed so products can be used singly or in combination to address specific health, wellness and recreational needs. Wana products are available in Colorado, California, Ohio, Illinois, Michigan, Arizona and Oregon dispensaries, with Oklahoma, Maryland and Florida (as regulations allow) among the states imminently coming online. Wana Brands expects to expand internationally to Canada by 2020. For more information or to subscribe to Wana’s e-newsletter, visit www.wanabrands.com. Follow Wana on LinkedIn, Twitter, YouTube and Pinterest.

About Curio Wellness:

Curio Wellness is a medicinal cannabis brand and trusted healthcare partner. We are a bold new voice in the quest for wellness – providing a growing patient population with a much-needed natural treatment for a vast number of disease states. Led by a proven and experienced executive and scientific team, our approach is rooted in science, complemented by strategic partnerships, and centered on superior patient care. Curio Wellness is one of 16 licensed growers and one of 17 licensed processors of medical cannabis in the state of Maryland and also operates a best in class holistic wellness center featuring the full complement of medicinal cannabis products from producers throughout the state. Curio Wellness products are also sold at more than 80 dispensaries throughout the state. For more information about Curio Wellness, please visithttp://curiowellness.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading